148 related articles for article (PubMed ID: 35909121)
1. Effect of stomach size on organs at risk in pancreatic stereotactic body radiotherapy.
Tanaka O; Taniguchi T; Adachi K; Nakaya S; Kiryu T; Ukai A; Makita C; Matsuo M
Radiat Oncol; 2022 Jul; 17(1):136. PubMed ID: 35909121
[TBL] [Abstract][Full Text] [Related]
2. Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer.
Karava K; Ehrbar S; Riesterer O; Roesch J; Glatz S; Klöck S; Guckenberger M; Tanadini-Lang S
Radiat Oncol; 2017 Nov; 12(1):175. PubMed ID: 29121945
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
[TBL] [Abstract][Full Text] [Related]
5. Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy.
Wang S; Zheng D; Lin C; Lei Y; Verma V; Smith A; Ma R; Enke CA; Zhou S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819851520. PubMed ID: 31195891
[TBL] [Abstract][Full Text] [Related]
6. Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model.
Nakamura A; Prichard HA; Wo JY; Wolfgang JA; Hong TS
J Appl Clin Med Phys; 2019 Feb; 20(2):71-83. PubMed ID: 30636367
[TBL] [Abstract][Full Text] [Related]
7. A Collimator Setting Optimization Algorithm for Dual-Arc Volumetric Modulated Arc Therapy in Pancreas Stereotactic Body Radiation Therapy.
Li X; Wu J; Palta M; Zhang Y; Sheng Y; Zhang J; Wang C
Technol Cancer Res Treat; 2019 Jan; 18():1533033819870767. PubMed ID: 31426721
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer.
Dai ZT; Ma L; Cao TT; Zhu L; Zhao M; Li N
Sci Rep; 2021 Feb; 11(1):4065. PubMed ID: 33603030
[TBL] [Abstract][Full Text] [Related]
9. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
[TBL] [Abstract][Full Text] [Related]
10. Simulated dose painting of hypoxic sub-volumes in pancreatic cancer stereotactic body radiotherapy.
Elamir AM; Stanescu T; Shessel A; Tadic T; Yeung I; Letourneau D; Kim J; Lukovic J; Dawson LA; Wong R; Barry A; Brierley J; Gallinger S; Knox J; O'Kane G; Dhani N; Hosni A; Taylor E
Phys Med Biol; 2021 Sep; 66(18):. PubMed ID: 34438383
[TBL] [Abstract][Full Text] [Related]
11. Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis.
Mayinger M; Ludwig R; Christ SM; Dal Bello R; Ryu A; Weitkamp N; Pavic M; Garcia Schüler H; Wilke L; Guckenberger M; Unkelbach J; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 May; 16(1):84. PubMed ID: 33947429
[TBL] [Abstract][Full Text] [Related]
12. Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.
Al-Hallaq HA; Chmura SJ; Salama JK; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Robinson CG; Pisansky TM; Winter KA; White JR; Xiao Y; Matuszak MM
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):155-163. PubMed ID: 27843033
[TBL] [Abstract][Full Text] [Related]
13. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
[TBL] [Abstract][Full Text] [Related]
14. Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images.
Young T; Lee M; Johnston M; Nguyen T; Ko R; Arumugam S
Phys Eng Sci Med; 2023 Dec; 46(4):1619-1627. PubMed ID: 37747645
[TBL] [Abstract][Full Text] [Related]
15. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
Gkika E; Adebahr S; Kirste S; Schimek-Jasch T; Wiehle R; Claus R; Wittel U; Nestle U; Baltas D; Grosu AL; Brunner TB
Strahlenther Onkol; 2017 Jun; 193(6):433-443. PubMed ID: 28138949
[TBL] [Abstract][Full Text] [Related]
17. Optimization of dose distributions of target volumes and organs at risk during stereotactic body radiation therapy for pancreatic cancer with dose-limiting auto-shells.
Cao Y; Zhu X; Ju X; Liu Y; Yu C; Sun Y; Dai Z; Guo X; Zhang H
Radiat Oncol; 2018 Jan; 13(1):11. PubMed ID: 29357875
[TBL] [Abstract][Full Text] [Related]
18. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer.
Taniguchi CM; Murphy JD; Eclov N; Atwood TF; Kielar KN; Christman-Skieller C; Mok E; Xing L; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1090-5. PubMed ID: 23273994
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk.
Loi M; Magallon-Baro A; Suker M; van Eijck C; Sharma A; Hoogeman M; Nuyttens J
Radiother Oncol; 2019 May; 134():67-73. PubMed ID: 31005226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
